Oncology & Cancer

Aspirin protects against Barrett's esophagus

Aspirin use appears to reduce the risk of Barrett's esophagus (BE), the largest known risk factor for esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice ...

Medical research

Research leads to new way of caring for pre-cancerous condition

A University of Manchester study of care provisions for patients diagnosed with Barrett's esophagus, a pre-cancerous condition, has resulted in improvements in local NHS care, which may form a blueprint for other hospitals.

Diseases, Conditions, Syndromes

Poor pathologist agreement for low-grade dysplasia in Barrett's

(HealthDay)—There is poor agreement between pathologists in diagnosis of low-grade dysplasia (LGD) in patients with Barrett's esophagus (BE), according to a study published in the February issue of Gastroenterology.

page 2 from 3